Plasma metabolomic profiles in liver cancer patients following stereotactic body radiotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Plasma metabolomic profiles in liver cancer patients following stereotactic body radiotherapy

Published:2020-09 Issue: Volume:59 Page:102973
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Ng Sylvia S.W.,Jang Gun Ho,Kurland Irwin J.,Qiu Yunping,Guha Chandan,Dawson Laura A.

Funder

the Canadian Institutes of Health Research

National Cancer Institute of Canada

the National Cancer Institute/National Institutes of Health

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference26 articles.

1. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma;Bujold;J Clin Oncol,2013

2. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients;Sanuki;Acta Oncol,2014

3. Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma;Yoon;PLoS One,2013

4. Local control after stereotactic body radiation therapy for liver tumors;Ohri;Int J Radiat Oncol Biol Phys,2018

5. Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma;Culleton;Radiother Oncol,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting effect of anti-PD-1/PD-L1 inhibitors therapy for hepatocellular carcinoma by detecting plasma metabolite based on UHPLC-MS;Frontiers in Immunology;2024-04-18

2. Microbiome and metabolome dynamics during radiotherapy for prostate cancer;Radiotherapy and Oncology;2023-12

3. Evolution of Response-Based Radiotherapy for Hepatocellular Cancer;The Cancer Journal;2023-09

4. Small molecule metabolites: discovery of biomarkers and therapeutic targets;Signal Transduction and Targeted Therapy;2023-03-20

5. Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment;Pharmacological Research;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3